As per the trusted sources of information, the new Drug introduced by Biogen, named as Adulelm are pricy and they are likely to cost Medicare about billions of dollars in a year, as stated by the nonprofit organization named Kaiser Family Foundation on Thursday.
The US FDA had approved of the Drug earlier this week. It is the first Drug approved by the FDA for slow cognitive decline for the people suffering from Alzheimer’s diseases. It is the first new medicine for the illness over last two decades.
Biogen states that their Drug is likely to be covered about almost 80% of the people who are suffering from Alzheimer’s, with the help of the federal health insurance program for the elderly.The company is yet to disclose about how the medical beneficiaries will handle the Drug. But even if we make a small estimate, it would cost a huge amount to the company.